<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02066857</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00071060</org_study_id>
    <nct_id>NCT02066857</nct_id>
  </id_info>
  <brief_title>Cast vs. Splints for Minimally Displaced Distal Radius Fractures in the Elderly</brief_title>
  <official_title>Use of Cast Versus Removable Splints for Minimally Displaced Distal Radius Fractures in Elderly Patients: A Prospective, Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Emory University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Emory University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this prospective randomized study is to add to the body of knowledge on the
      treatment of minimally displaced distal radius fractures in patients over 60 years of age.
      The investigators believe that treating minimally displaced distal radius fractures in people
      over 60 with a removable splint and early range of motion will provide greater patient
      satisfaction, fewer complications, and earlier functional returns to pre-injury for these
      patients compared to those treated with a short arm cast which immobilizes the limb for at
      least four weeks, and has been shown to lead to longer recovery and possible residual
      stiffness. The investigators hope to provide sufficient evidence in directing treatment that
      will give the most efficacious and the most satisfactory return of prior function to
      patients. Since distal radius fractures in the elderly are common because of poorer bone
      quality, the elderly proportion of the population is increasing, and controlling health costs
      is of current concern, answering the question of which treatment produces the best results
      for all these concerns is of increasing importance now.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Wrist Range of Motion (ROM)</measure>
    <time_frame>Baseline, Month 3</time_frame>
    <description>Wrist ROM will be assessed by a goniometer exam.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean Mayo Wrist Score</measure>
    <time_frame>Baseline, Week 2, Week 6, Week 12</time_frame>
    <description>The Mayo Wrist Score is a clinician-completed scoring system used to evaluate the level of functionality in the wrist, assessing pain, functional status (able to work), range of motion and grip strength. Total scores for functionality range from 0-100 and are categorized as follows: 90-100 indicates excellent, 80-90 indicates good, 60-80 indicates satisfactory, below 60 indicates poor. The assessment was completed at all study visits.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Grip Strength</measure>
    <time_frame>Baseline, Month 3</time_frame>
    <description>Grip strength will be assessed by bilateral dynamometer testing.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Complication Rate</measure>
    <time_frame>Duration of Study (Up to 3 Months)</time_frame>
    <description>The number of participants who experienced treatment related complications including the need for manipulation in the case of lost reduction.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean Pain Score</measure>
    <time_frame>Baseline, Week 2, Week 6, Week 12</time_frame>
    <description>Pain will be assessed by a visual analog scale (VAS). Participants rate their pain level in a scale from 0 to 10; 0 representing &quot;no pain&quot; and 10 representing &quot;the worst pain imaginable&quot;. The assessment was completed at all study visits.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean Disabilities of the Arm and Shoulder (DASH) Questionnaire Score</measure>
    <time_frame>Baseline, Week 2, Week 6, Week 12</time_frame>
    <description>The DASH questionnaire asks about symptoms as well as ability to perform certain activities. Scores range on a 0-100 scale. A higher score indicates greater disability.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in SF-12 QOL</measure>
    <time_frame>Baseline, Month 3</time_frame>
    <description>The SF-12 QOL is a self-administered measure asking views about participant's health and how well they are able to perform usual activities.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">5</enrollment>
  <condition>Radius; Fracture, Lower or Distal End</condition>
  <arm_group>
    <arm_group_label>Generic plaster or fiberglass cast group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will be randomized to receive a generic plaster or fiberglass cast for treatment of non-displaced distal radius fracture for 6 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Generic &quot;off the shelf&quot; removable splint group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will be randomized and receive a generic &quot;off the shelf&quot; removable splint for treatment of non-displaced distal radius fracture for 6 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cast made of generic plaster or fiberglass cast material</intervention_name>
    <description>Patients will randomly receive a generic plaster or fiberglass cast for treatment of non-displaced distal radius fracture.</description>
    <arm_group_label>Generic plaster or fiberglass cast group</arm_group_label>
    <other_name>No brand name applicable.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Generic &quot;off the shelf&quot; removable splint</intervention_name>
    <description>Patients will be randomized to receive a generic &quot;off the shelf&quot; removable splint for treatment of a non-displaced distal radius fracture.</description>
    <arm_group_label>Generic &quot;off the shelf&quot; removable splint group</arm_group_label>
    <other_name>No brand name applicable</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Colles' Fracture - Distal radius fracture with dorsal angulation, apex volar
             (satisfies non-operative radiographic criteria before or after reduction

          2. Isolated upper limb injury

          3. No previous wrist fracture

          4. Available for follow-up

          5. Between 60 and 100 years of age

        Exclusion Criteria:

          1. Less than 60 years of age

          2. Fractures that do not meet non-operative criteria or are deemed unstable by surgeon,
             subsequently requiring surgery after first clinic visit.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claudius Jarrett, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Emory University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Emory Orthopaedics and Spine Center</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30329</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 14, 2014</study_first_submitted>
  <study_first_submitted_qc>February 19, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 20, 2014</study_first_posted>
  <results_first_submitted>March 31, 2017</results_first_submitted>
  <results_first_submitted_qc>May 19, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">May 24, 2017</results_first_posted>
  <last_update_submitted>May 19, 2017</last_update_submitted>
  <last_update_submitted_qc>May 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Emory University</investigator_affiliation>
    <investigator_full_name>Claudius Jarrett</investigator_full_name>
    <investigator_title>Assistant Professor of Orthopaedics</investigator_title>
  </responsible_party>
  <keyword>Wrist fracture</keyword>
  <keyword>Radius fracture</keyword>
  <keyword>Elderly</keyword>
  <keyword>Splint</keyword>
  <keyword>Cast</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Radius Fractures</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calpastatin</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were recruited from the Emory Orthopaedic Fracture Clinic from April 2014 to November 2014.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Generic Plaster or Fiberglass Cast Group</title>
          <description>Participants were randomized to receive a generic plaster or fiberglass cast for treatment of non-displaced distal radius fracture for 6 weeks.</description>
        </group>
        <group group_id="P2">
          <title>Generic &quot;Off the Shelf&quot; Removable Splint Group</title>
          <description>Participants were randomized to receive a generic &quot;off the shelf&quot; removable splint for treatment of non-displaced distal radius fracture for 6 weeks.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Generic Plaster or Fiberglass Cast Group</title>
          <description>Participants were randomized to receive a generic plaster or fiberglass cast for treatment of non-displaced distal radius fracture for 6 weeks.</description>
        </group>
        <group group_id="B2">
          <title>Generic &quot;Off the Shelf&quot; Removable Splint Group</title>
          <description>Participants were randomized to receive a generic &quot;off the shelf&quot; removable splint for treatment of non-displaced distal radius fracture for 6 weeks.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1"/>
            <count group_id="B2" value="4"/>
            <count group_id="B3" value="5"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Wrist Range of Motion (ROM)</title>
        <description>Wrist ROM will be assessed by a goniometer exam.</description>
        <time_frame>Baseline, Month 3</time_frame>
        <population>Data for this outcome measure are not available for analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Generic Plaster or Fiberglass Cast Group</title>
            <description>Participants were randomized to receive a generic plaster or fiberglass cast for treatment of non-displaced distal radius fracture for 6 weeks.</description>
          </group>
          <group group_id="O2">
            <title>Generic &quot;Off the Shelf&quot; Removable Splint Group</title>
            <description>Participants were randomized to receive a generic &quot;off the shelf&quot; removable splint for treatment of non-displaced distal radius fracture for 6 weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Wrist Range of Motion (ROM)</title>
          <description>Wrist ROM will be assessed by a goniometer exam.</description>
          <population>Data for this outcome measure are not available for analysis.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Mean Mayo Wrist Score</title>
        <description>The Mayo Wrist Score is a clinician-completed scoring system used to evaluate the level of functionality in the wrist, assessing pain, functional status (able to work), range of motion and grip strength. Total scores for functionality range from 0-100 and are categorized as follows: 90-100 indicates excellent, 80-90 indicates good, 60-80 indicates satisfactory, below 60 indicates poor. The assessment was completed at all study visits.</description>
        <time_frame>Baseline, Week 2, Week 6, Week 12</time_frame>
        <population>Of the 5 participants who were enrolled, data were analyzed for the 3 participants who completed all study visits.</population>
        <group_list>
          <group group_id="O1">
            <title>Generic &quot;Off the Shelf&quot; Removable Splint Group</title>
            <description>Participants were randomized to receive a generic &quot;off the shelf&quot; removable splint for treatment of non-displaced distal radius fracture for 6 weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Mayo Wrist Score</title>
          <description>The Mayo Wrist Score is a clinician-completed scoring system used to evaluate the level of functionality in the wrist, assessing pain, functional status (able to work), range of motion and grip strength. Total scores for functionality range from 0-100 and are categorized as follows: 90-100 indicates excellent, 80-90 indicates good, 60-80 indicates satisfactory, below 60 indicates poor. The assessment was completed at all study visits.</description>
          <population>Of the 5 participants who were enrolled, data were analyzed for the 3 participants who completed all study visits.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.67" spread="16.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.67" spread="20.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.33" spread="2.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Grip Strength</title>
        <description>Grip strength will be assessed by bilateral dynamometer testing.</description>
        <time_frame>Baseline, Month 3</time_frame>
        <population>Data for this outcome measure are not available for analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Generic Plaster or Fiberglass Cast Group</title>
            <description>Participants were randomized to receive a generic plaster or fiberglass cast for treatment of non-displaced distal radius fracture for 6 weeks.</description>
          </group>
          <group group_id="O2">
            <title>Generic &quot;Off the Shelf&quot; Removable Splint Group</title>
            <description>Participants were randomized to receive a generic &quot;off the shelf&quot; removable splint for treatment of non-displaced distal radius fracture for 6 weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Grip Strength</title>
          <description>Grip strength will be assessed by bilateral dynamometer testing.</description>
          <population>Data for this outcome measure are not available for analysis.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Complication Rate</title>
        <description>The number of participants who experienced treatment related complications including the need for manipulation in the case of lost reduction.</description>
        <time_frame>Duration of Study (Up to 3 Months)</time_frame>
        <population>Of the 5 participants who were enrolled, data were analyzed for the 3 participants who completed all study visits.</population>
        <group_list>
          <group group_id="O1">
            <title>Generic &quot;Off the Shelf&quot; Removable Splint Group</title>
            <description>Participants were randomized to receive a generic &quot;off the shelf&quot; removable splint for treatment of non-displaced distal radius fracture for 6 weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>Complication Rate</title>
          <description>The number of participants who experienced treatment related complications including the need for manipulation in the case of lost reduction.</description>
          <population>Of the 5 participants who were enrolled, data were analyzed for the 3 participants who completed all study visits.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Mean Pain Score</title>
        <description>Pain will be assessed by a visual analog scale (VAS). Participants rate their pain level in a scale from 0 to 10; 0 representing &quot;no pain&quot; and 10 representing &quot;the worst pain imaginable&quot;. The assessment was completed at all study visits.</description>
        <time_frame>Baseline, Week 2, Week 6, Week 12</time_frame>
        <population>Of the 5 participants who were enrolled, data were analyzed for the 3 participants who completed all study visits.</population>
        <group_list>
          <group group_id="O1">
            <title>Generic &quot;Off the Shelf&quot; Removable Splint Group</title>
            <description>Participants were randomized to receive a generic &quot;off the shelf&quot; removable splint for treatment of non-displaced distal radius fracture for 6 weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Pain Score</title>
          <description>Pain will be assessed by a visual analog scale (VAS). Participants rate their pain level in a scale from 0 to 10; 0 representing &quot;no pain&quot; and 10 representing &quot;the worst pain imaginable&quot;. The assessment was completed at all study visits.</description>
          <population>Of the 5 participants who were enrolled, data were analyzed for the 3 participants who completed all study visits.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6" spread="3.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.66" spread="3.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.67" spread="1.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".33" spread=".58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Disabilities of the Arm and Shoulder (DASH) Questionnaire Score</title>
        <description>The DASH questionnaire asks about symptoms as well as ability to perform certain activities. Scores range on a 0-100 scale. A higher score indicates greater disability.</description>
        <time_frame>Baseline, Week 2, Week 6, Week 12</time_frame>
        <population>Of the 5 participants who were enrolled, data were analyzed for the 3 participants who completed all study visits.</population>
        <group_list>
          <group group_id="O1">
            <title>Generic &quot;Off the Shelf&quot; Removable Splint Group</title>
            <description>Participants were randomized to receive a generic &quot;off the shelf&quot; removable splint for treatment of non-displaced distal radius fracture for 6 weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Disabilities of the Arm and Shoulder (DASH) Questionnaire Score</title>
          <description>The DASH questionnaire asks about symptoms as well as ability to perform certain activities. Scores range on a 0-100 scale. A higher score indicates greater disability.</description>
          <population>Of the 5 participants who were enrolled, data were analyzed for the 3 participants who completed all study visits.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73.03" spread="23.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.63" spread="27.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.33" spread="22.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.67" spread="16.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in SF-12 QOL</title>
        <description>The SF-12 QOL is a self-administered measure asking views about participant's health and how well they are able to perform usual activities.</description>
        <time_frame>Baseline, Month 3</time_frame>
        <population>No participants completed this survey as this outcome measure was removed from the protocol. No data were collected.</population>
        <group_list>
          <group group_id="O1">
            <title>Generic Plaster or Fiberglass Cast Group</title>
            <description>Participants were randomized to receive a generic plaster or fiberglass cast for treatment of non-displaced distal radius fracture for 6 weeks.</description>
          </group>
          <group group_id="O2">
            <title>Generic &quot;Off the Shelf&quot; Removable Splint Group</title>
            <description>Participants were randomized to receive a generic &quot;off the shelf&quot; removable splint for treatment of non-displaced distal radius fracture for 6 weeks.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in SF-12 QOL</title>
          <description>The SF-12 QOL is a self-administered measure asking views about participant's health and how well they are able to perform usual activities.</description>
          <population>No participants completed this survey as this outcome measure was removed from the protocol. No data were collected.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were collection for the duration of the study (2 years).</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Generic Plaster or Fiberglass Cast Group</title>
          <description>Participants were randomized to receive a generic plaster or fiberglass cast for treatment of non-displaced distal radius fracture for 6 weeks.</description>
        </group>
        <group group_id="E2">
          <title>Generic &quot;Off the Shelf&quot; Removable Splint Group</title>
          <description>Participants were randomized to receive a generic &quot;off the shelf&quot; removable splint for treatment of non-displaced distal radius fracture for 6 weeks.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>A small number of participants was analyzed due to limited enrollment and completion rates.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Claude Jarrett, M.D.</name_or_title>
      <organization>Emory University</organization>
      <phone>404-778-8099</phone>
      <email>CJarrett@wilmingtonhealth.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

